相关实验视频
Updated: Jun 7, 2025

09:25
A Protocol to Acquire the Degenerative Tenocyte from Humans
Published on: June 9, 2018
7.3K
通过增强EGFR/MAPK信号通路,CTHRC1可以减轻肌病
Cheng Chen1, Xu Zheng2,3, Cheng Wang3
1Department of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 14, 2024
概括
原三环重复含有1 (CTHRC1) 通过增强细胞生长和分化,促进肌愈合. 这种细胞外基质蛋白激活EGFR/MAPK通路,为肌病提供了潜在的治疗标.
科学领域:
- 生物化学 生物化学
- 再生医学是一种再生医学.
- 整形外科 整形外科 整形外科
背景情况:
- 肌病因肌愈合能力有限而构成重大临床挑战.
- 目前用于肌病的治疗方法缺乏明确的治疗方法.
- 原三环重复含有1 (CTHRC1) 是一种细胞外基质蛋白,涉及各种生物过程.
研究的目的:
- 研究CTHRC1在肌病中的作用和机制.
- 探索CTHRC1作为肌再生治疗剂的潜力.
主要方法:
- 鼠标阿基里斯肌组织的多蛋白质分析.
- 肌干细胞/原生细胞 (TSPC) 的体外研究评估了增殖,迁移和肌基分化.
- 在体内研究涉及CTHRC1删除和过度表达在小鼠模型.
- 用重组CTHRC1刺激TSPC的蛋白质组分析以确定信号通路.
主要成果:
- 确定CTHRC1是促进肌再生的关键因素.
- 在体外,CTHRC1增强了TSPC的增殖,迁移和基分化.
- 在体内,CTHRC1缺乏会影响肌愈合,而过度表达会挽救这些效应.
- CTHRC1激活了表皮生长因子受体 (EGFR) /线粒体激活蛋白激酶 (MAPK) 信号通路.
结论:
- CTHRC1通过EGFR/MAPK通路增强TSPC能力,促进肌愈合.
- CTHRC1促进肌再生,表明其作为肌病的治疗干预的潜力.
相关概念视频
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Enzyme-linked Receptors
77.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.4K
Receptor Tyrosine Kinases
12.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.3K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K

